Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Rezo Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Rezo Therapeutics

Rezo Therapeutics

Rezo: A biopharma company revolutionizing drug development with a disease-agnostic network biology platform.

HQ
South San Francisco, CA, US
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to revolutionize drug development, Rezo Therapeutics is a biopharma company leveraging a disease-agnostic, fully-integrated network biology platform. Their core vision is to redefine the understanding of human diseases and enhance the ability to treat them effectively. By mapping disease networks, Rezo aims to unlock new insights and opportunities in drug discovery, targeting a broad spectrum of conditions without being confined to specific diseases.

Rezo Therapeutics has attracted notable investors and industry experts who believe in their innovative approach to drug development. The company has made significant strides in advancing its platform, contributing to a deeper understanding of disease mechanisms and potential therapeutic targets. Their impact on the biopharma industry is marked by their commitment to increasing the success rate of drug development, ultimately aiming to improve patient outcomes across various diseases.

Rezo Therapeutics - Similar Companies

Algen Biotechnologies logo

Algen Biotechnologies

algenbio.com

ReviR Therapeutics logo

ReviR Therapeutics

revirtx.com

Rejuveron Life Sciences logo

Rejuveron Life Sciences

rejuveron.com

Reactive Biosciences logo

Reactive Biosciences

reactivebio.com

Empirico logo

Empirico

empiricotx.com

Reservoir Neuroscience logo

Reservoir Neuroscience

reservoirneuro.com

Exo Therapeutics logo

Exo Therapeutics

Ensem Therapeutics logo

Ensem Therapeutics

ensemtx.com

Ventus Therapeutics logo

Ventus Therapeutics

Reset Pharmaceuticals logo

Reset Pharmaceuticals

Unravel Biosciences logo

Unravel Biosciences

unravel.bio

Actio Biosciences logo

Actio Biosciences

actiobio.com

NeuroX1 logo

NeuroX1

neurox1.com

BioXcel Therapeutics logo

BioXcel Therapeutics

TRex Bio logo

TRex Bio

trex.bio

Rezo Therapeutics - Quick Facts

Who are Rezo Therapeutics' competitors?

Companies similar to Rezo Therapeutics include Algen Biotechnologies, ReviR Therapeutics, Rejuveron Life Sciences and Reactive Biosciences.

Where is Rezo Therapeutics' headquarters located?

Rezo Therapeutics' headquarters is located in South San Francisco, CA, US.

When was Rezo Therapeutics' last funding round?

Rezo Therapeutics' most recent funding round was for $78M (USD) in November 2022.

How much has Rezo Therapeutics raised to-date?

As of Nov 17, 2022, Rezo Therapeutics has raised a total of $78M (USD).

How many employees does Rezo Therapeutics have?

Rezo Therapeutics has 30 employees as of Feb 5, 2024.

Rezo Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • AI
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Drug Discovery
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified